US Stock MarketDetailed Quotes

DWTX Dogwood Therapeutics

Watchlist
  • 2.340
  • +0.020+0.86%
Close Dec 20 16:00 ET
  • 2.340
  • 0.0000.00%
Post 20:01 ET
3.12MMarket Cap-0.37P/E (TTM)

Dogwood Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Dogwood Therapeutics Q3 2024 Earnings Date

Currency：USDNov 7, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
0
0
0
--
--
--
EPS
-0.78
-2.05
-1.27
Miss Est.
+48.22%
-26.54%
-163.97%
Analyst Rating
Buy

Nov 30, 2024

Dogwood Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 7, 20242024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 7, 20242024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Dogwood Therapeutics Earnings Reports

  • Dogwood Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 8 21:19

  • Dogwood Therapeutics | 8-K: Dogwood Therapeutics Announces Third Quarter 2024 Financial Results

    Nov 7 20:18

  • Virios Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 9 22:17

  • Virios Therapeutics | 8-K: Virios Therapeutics Announces Second Quarter 2024 Financial Results

    Aug 8 21:34

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Buy

    • Buy

      50.00%

    • Hold

      50.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data